Trametinib Safety and Efficacy in Non–V600 BRAF–Mutant Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase I Study
Oncologist 2021 Apr 16;[EPub Ahead of Print], CA Nebhan, DB Johnson, RJ Sullivan, RN Amaria, KT Flaherty, JA Sosman, MA DaviesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.